The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · cited 1×
“Although initially thought to be involved solely in the DNA damage checkpoint in G1, p21was later shown to play a crucial role in the G2-phase checkpoint in human cells [40–42].”
Backgroundp21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · cited 3×
“Most of the mechanisms regulating p21 expression at the transcriptional level, have been extensively described elsewhere [2,5,53], and they will be not further discussed.”
BackgroundWAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
PCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Radiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 1×
“Additionally, mouse embryonic fibroblasts (MEFs) obtained fromp21-nullmice fail to arrest in G1 phase in response to DNA damage [25,26].”
BackgroundLife and death partners: apoptosis, autophagy and the cross-talk between them
Eisenberg-Lerner, A., Bialik, S., Simon, H.-U., & Kimchi, A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.33 · Cited by 1,183
CDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106 · cited 1×
“It has been shown that the cytoplasmic fraction of p53 triggers apoptosis and inhibits autophagy, while in the nucleus p53 acts as an autophagy-inducing transcription factor [86,87].”
BackgroundInhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNA
Gulbis, J. M., Kelman, Z., Hurwitz, J., O'Donnell, M., & Kuriyan, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81347-1 · Cited by 804
DNA damage checkpoints: from initiation to recovery or adaptation
Bartek, J., & Lukas, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.009 · Cited by 784 · cited 1×
“This pathway consists of DNA damage signaling cascade (cell cycle checkpoints), and of DNA repair processes able to recognize and remove a great number of DNA lesions [1].”
BackgroundNew roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?
Coqueret, O. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)00043-0 · Cited by 751
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728
Niculescu, A. B., Chen, X., Smeets, M., Hengst, L., Prives, C., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.629 · Cited by 724
Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator
Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D. H., & Nabel, G. J. (1997) · Science · doi:10.1126/science.275.5299.523 · Cited by 722
Seoane, J., Le, H.-V., & Massagué, J. (2002) · Nature · doi:10.1038/nature01119 · Cited by 684
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation
Asada, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1223 · Cited by 586
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
Luo, Y., Hurwitz, J., & Massagué, J. (1995) · Nature · doi:10.1038/375159a0 · Cited by 549
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A. (1995) · Nature · doi:10.1038/374386a0 · Cited by 548 · cited 2×
“The idea that p21 could play a role in DNA repair was first suggested by the evidence showing that p21 interacts with PCNA [9,10,13–16].”
BackgroundRNA Helicase A Mediates Association of CBP with RNA Polymerase II
Nakajima, T., Uchida, C., Anderson, S. F., Lee, C.-G., Hurwitz, J., Parvin, J. D., & Montminy, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80376-1 · Cited by 540
Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase
Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., & Hershko, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301774200 · Cited by 494
p21WAF1/Cip1: more than a break to the cell cycle?
Dotto, G. P. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00019-6 · Cited by 474
Levkau, B., Koyama, H., Raines, E. W., Clurman, B. E., Herren, B., Orth, K., Roberts, J. M., & Ross, R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80055-6 · Cited by 441
Control of autophagy by oncogenes and tumor suppressor genes
Maiuri, M. C., Tasdemir, E., Criollo, A., Morselli, E., Vicencio, J. M., Carnuccio, R., & Kroemer, G. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.131 · Cited by 435
Chang, B.-D., Watanabe, K., Broude, E. V., Fang, J., Poole, J. C., Kalinichenko, T. V., & Roninson, I. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4291 · Cited by 432
Smith, M. L., Ford, J. M., Hollander, M. C., Bortnick, R. A., Amundson, S. A., Seo, Y. R., Deng, C., Hanawalt, P. C., & Fornace, A. J. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3705-3714.2000 · Cited by 432
Tumor susceptibility of p21(Waf1/Cip1)-deficient mice.
Martín‐Caballero, J., Flores, J. M., García, P., & Serrano, M. (2001) · PubMed · Cited by 429
Flores-Rozas, H., Kelman, Z., Dean, F. B., Pan, Z. Q., Harper, J. W., Elledge, S. J., O'Donnell, M., & Hurwitz, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8655 · Cited by 416
Cell-cycle arrest versus cell death in cancer therapy
Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., & Williams, J. (1997) · Nature Medicine · doi:10.1038/nm0997-1034 · Cited by 389
Abbas, T., Sivaprasad, U., Terai, K., Amador, V., Pagano, M., & Dutta, A. (2008) · Genes & Development · doi:10.1101/gad.1676108 · Cited by 366
Nuclear Accumulation of p21 Cip1 at the Onset of Mitosis: a Role at the G 2 /M-Phase Transition
Dulić, V., Stein, G. H., Far, D. F., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.546 · Cited by 353
Suzuki, A., Tsutomi, Y., Akahane, K., Araki, T., & Miura, M. (1998) · Oncogene · doi:10.1038/sj.onc.1202021 · Cited by 350
p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells
Cayrol, C., Knibiehler, M., & Ducommun, B. (1998) · Oncogene · doi:10.1038/sj.onc.1201543 · Cited by 337
Missero, C., Calautti, E., Eckner, R., Chin, J., Tsai, L. H., Livingston, D. M., & Dotto, G. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5451 · Cited by 328
Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation
Bloom, J., Amador, V., Bartolini, F., DeMartino, G., & Pagano, M. (2003) · Cell · doi:10.1016/s0092-8674(03)00755-4 · Cited by 322
Cyclin-Binding Motifs Are Essential for the Function of p21 CIP1
Chen, J., Saha, P., Kornbluth, S., Dynlacht, B. D., & Dutta, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4673 · Cited by 320
Warbrick, E., Lane, D. P., Glover, D. M., & Cox, L. S. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00058-3 · Cited by 277
Brugarolas, J., Moberg, K., Boyd, S. D., Taya, Y., Jacks, T., & Lees, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1002 · Cited by 276
The acetyltransferase activity of CBP stimulates transcription
Martínez‐Balbás, M. A., Bannister, A. J., Martin, K., Haus‐Seuffert, P., Meisterernst, M., & Kouzarides, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2886 · Cited by 266 · cited 1×
“These proteins are essential co-activators that stimulate gene expression through their acetyl transferase activity, or through their ability to interact with components of the transcriptional machinery [104,105].”
BackgroundMDM2 Is a Negative Regulator of p21 , Independent of p53
Zhang, Z., Wang, H., Li, M., Agrawal, S., Chen, X., & Zhang, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312264200 · Cited by 252
UV Irradiation Triggers Ubiquitin-Dependent Degradation of p21WAF1 to Promote DNA Repair
Bendjennat, M., Boulaire, J., Jascur, T., Brickner, H., Barbier, V., Sarasin, A., Fotedar, A., & Fotedar, R. (2003) · Cell · doi:10.1016/j.cell.2003.08.001 · Cited by 248
The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing
Kim, Y., Starostina, N. G., & Kipreos, E. T. (2008) · Genes & Development · doi:10.1101/gad.1703708 · Cited by 240
Nishitani, H., Shiomi, Y., Iida, H., Michishita, M., Takami, T., & Tsurimoto, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806045200 · Cited by 240
p21Waf1/Cip1 as a therapeutic target in breast and other cancers
Weiss, R. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00308-8 · Cited by 237
Touitou, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2367 · Cited by 236
p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage
Rubbi, C. P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg082 · Cited by 232
p21 Inhibits Thr161 Phosphorylation of Cdc2 to Enforce the G2 DNA Damage Checkpoint
Smits, V. A. J., Klompmaker, R., Vallenius, T., Rijksen, G., Mäkelä, T. P., & Medema, R. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005437200 · Cited by 221
Proteasome-Dependent Regulation of p21WAF1/CIP1Expression
Blagosklonny, M. V., Wu, G. S., Omura, S., & El-Deiry, W. S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1546 · Cited by 221
Huang, S., Shu, L., Dilling, M. B., Easton, J., Harwood, F. C., Ichijo, H., & Houghton, P. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00180-1 · Cited by 216
Gervais, J. L. M., Seth, P., & Zhang, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19207 · Cited by 212
Devgan, V., Mammucari, C., Millar, S. E., Brisken, C., & Dotto, G. P. (2005) · Genes & Development · doi:10.1101/gad.341405 · Cited by 209 · cited 1×
“It has been shown that p21 prevents the recruitment of p300 on the Wnt4 gene promoter, causing histone hypoacetylation and transcriptional repression [106].”
BackgroundAPC/CCdc20 Controls the Ubiquitin-Mediated Degradation of p21 in Prometaphase
Amador, V., Ge, S., Santamaría, P. G., Guardavaccaro, D., & Pagano, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.013 · Cited by 209
p21-Mediated Nuclear Retention of Cyclin B1-Cdk1 in Response to Genotoxic Stress
Charrier-Savournin, F. B., Château, M.-T., Gire, V., Sedivy, J., Piette, J., & Dulić, V. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-12-0871 · Cited by 202
Control of E2F activity by p21Waf1/Cip1
Delavaine, L., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202923 · Cited by 188
CUL4A Abrogation Augments DNA Damage Response and Protection against Skin Carcinogenesis
Liu, L., Lee, S., Zhang, J., Peters, S. B., Hannah, J., Zhang, Y., Yin, Y., Koff, A., Ma, L., & Zhou, P. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.020 · Cited by 185
Child, E. S., & Mann, D. J. (2006) · Cell Cycle · doi:10.4161/cc.5.12.2863 · Cited by 184
Niculescu, A. B., Chen, X., Smeets, M. F. M. A., Hengst, L., Prives, C. L., & Reed, S. I. (1998) · Molecular and Cellular Biology · Cited by 177
Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis
Hasan, S., Hassa, P. O., Imhof, R., & Hottiger, M. O. (2001) · Nature · doi:10.1038/35066610 · Cited by 176
Functional Interaction of STAT3 Transcription Factor with the Cell Cycle Inhibitor p21
Coqueret, O., & Gascan, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001601200 · Cited by 175
Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision—repair
Shivji, M. K. K., Grey, S. J., Strausfeld, U. P., Wood, R. D., & Blow, J. J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00244-x · Cited by 170
p21 Inhibits Cdk1 in the Absence of Cdk2 to Maintain the G1/S Phase DNA Damage Checkpoint
Satyanarayana, A., Hilton, M. B., & Kaldis, P. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0525 · Cited by 167
Are p27 and p21 Cytoplasmic Oncoproteins?
Blagosklonny, M. V. (2002) · Cell Cycle · doi:10.4161/cc.1.6.262 · Cited by 165
Coleman, M. L., Marshall, C. J., & Olson, M. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg189 · Cited by 164
Mocquet, V., Lainé, J. P., Riedl, T., Yajin, Z., Lee, M. Y., & Egly, J. M. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601948 · Cited by 164
Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage
Li, R., Hannon, G. J., Beach, D., & Stillman, B. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00452-9 · Cited by 161
Suzuki, A., Tsutomi, Y., Miura, M., & Akahane, K. (1999) · Oncogene · doi:10.1038/sj.onc.1202409 · Cited by 161
Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis
Lee, E., Lee, M., Camus, S., Ghim, J., Yang, M., Oh, W., Ha, N., Lane, D. P., & Song, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.164 · Cited by 160
Liu, S., Bishop, W. R., & Liu, M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00044-x · Cited by 158
Repair Defect in p21 WAF1/CIP1 -/- human cancer cells.
McDonald, E. R., Wu, G. S., Waldman, T. A., & El‐Deiry, W. S. (1996) · PubMed · Cited by 155
Arima, Y., Hirota, T., Bronner, C., Mousli, M., Fujiwara, T., Niwa, S., Ishikawa, H. T., & Saya, H. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00710.x · Cited by 152
Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21
Pan, Z.-Q., Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A., & Hurwitz, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22008 · Cited by 151
Jin, Y. H., Yoo, K. J., Lee, Y. H., & Lee, S. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001902200 · Cited by 147
Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21
Cayrol, C., & Ducommun, B. (1998) · Oncogene · doi:10.1038/sj.onc.1202189 · Cited by 147
Sohn, D., Eßmann, F., Schulze‐Osthoff, K., & Jänicke, R. U. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1569 · Cited by 146
Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts
Baus, F., Gire, V., Fisher, D., Piette, J., & Dulić, V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg387 · Cited by 143 · cited 1×
“Other likely targets of p21 in G2 phase are cyclin A-CDK1/2 complexes [45,46].”
Backgroundp53 and p21 Regulate Error-Prone DNA Repair to Yield a Lower Mutation Load
Avkin, S., Sevilya, Z., Toube, L., Geacintov, N. E., Chaney, S. G., Oren, M., & Livneh, Z. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.022 · Cited by 140
Kitaura, H., Shinshi, M., Uchikoshi, Y., Ono, T., Tsurimoto, T., Yoshikawa, H., Iguchi‐Ariga, S. M. M., & Ariga, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10477 · Cited by 137
CBP/p300 and muscle differentiation: no HAT, no muscle
Polesskaya, A., Naguibneva, I., Fritsch, L., Duquet, A., Ait‐Si‐Ali, S., Robin, P., Vervisch, A., Pritchard, L. L., Cole, P., & Harel‐Bellan, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6816 · Cited by 134
Rousseau, D. L., Cannella, D., Boulaire, J., FITZGERALD, P. J., Fotedar, A., & Fotedar, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202681 · Cited by 133
Datto, M., Hu, P. P.-C., Kowalik, T. F., Yingling, J. M., & Wang, X. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2030 · Cited by 128
The Multiple Battles Fought by Anti-Apoptotic p21
Jänicke, R. U., Sohn, D., Eßmann, F., & Schulze‐Osthoff, K. (2007) · Cell Cycle · doi:10.4161/cc.6.4.3855 · Cited by 127
Tian, H., Wittmack, E. K., & Jorgensen, T. J. (2000) · PubMed · Cited by 125
Podust, V. N., Podust, L. M., Goubin, F., Ducommun, B., & Huebscher, U. (1995) · Biochemistry · doi:10.1021/bi00027a039 · Cited by 124
The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis
Gartel, A. L. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.04.023 · Cited by 120
Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.
Goubin, F., & Ducommun, B. (1995) · PubMed · Cited by 120
Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death
Garner, E., & Raj, K. (2008) · Cell Cycle · doi:10.4161/cc.7.3.5328 · Cited by 119
Pivotal Role of the Cyclin-dependent Kinase Inhibitor p21WAF1/CIP1 in Apoptosis and Autophagy
Fujiwara, K., Daido, S., Yamamoto, A., Kobayashi, R., Yokoyama, T., Aoki, H., Iwado, E., Shinojima, N., Kondo, Y., & Kondo, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611043200 · Cited by 112
P21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation
Soria, G., Podhajcer, O. L., Prives, C. L., & Gottifredi, V. (2005) · Oncogene · doi:10.1038/sj.onc.1209315 · Cited by 109
DDB2 decides cell fate following DNA damage
Stoyanova, T., Roy, N., Kopanja, D., Bagchi, S., & Raychaudhuri, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812254106 · Cited by 108 · cited 1×
“Remarkably, cell exposure to sub-lethal DNA damaging conditions, do not lead to evident p21 degradation [80,130,158], while under stress conditions induced by DNA damaging agents, p21 degradation, as stimulated by E3 ligases associatedwithMKRN1 or DDB2, has been shown to facilitate the apoptotic cell death pathway, as…”
BackgroundSheikh, M. S., Chen, Y. Q., Smith, M. L., & Fornace, A. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201004 · Cited by 104
Chopin, V., Toillon, R., Jouy, N., & Bourhis, X. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207020 · Cited by 98
Lee, J. Y., Yu, S., Park, Y. G., Kim, J., & Sohn, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01461-06 · Cited by 98
Soria, G., Speroni, J., Podhajcer, O. L., Prives, C., & Gottifredi, V. (2008) · Journal of Cell Science · doi:10.1242/jcs.027730 · Cited by 94
p21WAF1/CIP1 Selectively Controls the Transcriptional Activity of Estrogen Receptor α
Fritah, A., Saucier, C., Mešter, J., Redeuilh, G., & Sabbah, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2419-2430.2005 · Cited by 94
Chen, J., Peters, R. J., Saha, P., Lee, P. P., Theodoras, A. M., Pagano, M., Wagner, G., & Dutta, A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.9.1727 · Cited by 94
Human Proliferating Cell Nuclear Antigen, Poly(ADP-ribose) Polymerase-1, and p21 /
Frouin, I., Maga, G., Denegri, M., Riva, F., Savio, M., Spadari, S., Prosperi, E., & Scovassi, A. I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300098200 · Cited by 93
Self-citationMcKay, B. C., Ljungman, M. E., & Rainbow, A. J. (1998) · Oncogene · doi:10.1038/sj.onc.1201963 · Cited by 92
The p21 and PCNA partnership: A new twist for an old plot
Prives, C. L., & Gottifredi, V. (2008) · Cell Cycle · doi:10.4161/cc.7.24.7243 · Cited by 91
Fotedar, R., FITZGERALD, P. J., Rousselle, T., Cannella, D., Dorée, M., Messier, H., & Fotedar, A. (1996) · PubMed · Cited by 89
p21 Disrupts the Interaction between cdk2 and the E2F-p130 Complex
Shiyanov, P. A., Bagchi, S., Adami, G. R., Kokontis, J. M., Hay, N., Arroyo, M., Morozov, A., & Raychaudhuri, P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.737 · Cited by 88
Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen, I. T., Akamatsu, M., Smith, M., Lung, F. T., Duba, D. E., Roller, P. P., Fornace, A. J., & O'Connor, P. M. (1996) · PubMed · Cited by 88
Not Just a CDK Inhibitor: Regulation of Transcription by p21WAF1/CIP1/SDI1
Perkins, N. D. (2002) · Cell Cycle · doi:10.4161/cc.1.1.98 · Cited by 87
Revisiting the rodent repairadox
Hanawalt, P. C. (2001) · Environmental and Molecular Mutagenesis · doi:10.1002/em.1057 · Cited by 85
p21Cip1/WAF1mediates cyclin B1 degradation in response to DNA damage
Gillis, L. D., Leidal, A. M., Hill, R., & Lee, P. W. K. (2009) · Cell Cycle · doi:10.4161/cc.8.2.7550 · Cited by 84
Adimoolam, S., Lin, C., & Ford, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102240200 · Cited by 82
Martinez, L. A., Yang, J., Vazquez, E. S., Rodriguez-Vargas, M. D. C., Olivé, M., Hsieh, J., Logothetis, C. J., & Navone, N. M. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1289 · Cited by 81
The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo
Cooper, M. P., Balajee, A. S., & Bohr, V. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.7.2119 · Cited by 80 · cited 1×
“A similar effect was observedwhen purified p21 protein was introduced into cells by electroporation [116].”
MethodOku, T., Ikeda, S., Sasaki, H., Fukuda, K., Morioka, H., Ohtsuka, E., Yoshikawa, H., & Tsurimoto, T. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00199.x · Cited by 77
Ruan, S., Okcu, M. F., Ren, J. P., Chiao, P. J., Andreeff, M., Levin, V. A., & Zhang, W. (1998) · PubMed · Cited by 77
Vigneron, A. M., Cherier, J., Barré, B., Gamelin, E. C., & Coqueret, O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602492200 · Cited by 77
Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block
Gottifredi, V., McKinney, K., Poyurovsky, M. V., & Prives, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310373200 · Cited by 76
An antisense oligodeoxynucleotide to p21(Waf1/Cip1) causes apoptosis in human breast cancer cells.
Fan, Y., Borowsky, A. D., & Weiss, R. H. (2003) · PubMed · Cited by 74
Regulatory Roles of p21 and Apurinic/Apyrimidinic Endonuclease 1 in Base Excision Repair
Tom, S., Ranalli, T. A., Podust, V. N., & Bambara, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109626200 · Cited by 73
Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1
Shivji, M. K., Ferrari, E., Ball, K., Hübscher, U., & Wood, R. D. (1998) · Oncogene · doi:10.1038/sj.onc.1202352 · Cited by 72
DNA Damage Triggers p21WAF1-dependent Emi1 Down-Regulation That Maintains G2 Arrest
Lee, J., Kim, J. A., Barbier, V., Fotedar, A., & Fotedar, R. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0818 · Cited by 68
Cazzalini, O., Perucca, P., Riva, F., Stivala, L. A., Bianchi, L. C., Vannini, V., Ducommun, B., & Prosperi, E. (2003) · Cell Cycle · doi:10.4161/cc.2.6.502 · Cited by 67
Self-citationEffect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells
Fotedar, R., Brickner, H., Saadatmandi, N., Rousselle, T., Diederich, L., Munshi, A., Jung, B. H., Reed, J. C., & Fotedar, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202693 · Cited by 67
Cazzalini, O., Perucca, P., Savio, M., Necchi, D., Bianchi, L. C., Stivala, L. A., Ducommun, B., Scovassi, A. I., & Prosperi, E. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn014 · Cited by 64
Self-citationZhu, H., Chang, B.-D., Uchiumi, T., & Roninson, I. B. (2002) · PubMed · Cited by 63
Baptiste-Okoh, N., Barsotti, A. M., & Prives, C. L. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5805 · Cited by 61
Jakob, B., Scholz, M., & Taucher-Scholz, G. (2002) · International Journal of Radiation Biology · doi:10.1080/09553000110090007 · Cited by 60
Stivala, L. A., Riva, F., Cazzalini, O., Savio, M., & Prosperi, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204132 · Cited by 57
Self-citationCazzalini, O., Donà, F., Savio, M., Tillhon, M., Maccario, C., Perucca, P., Stivala, L. A., Scovassi, A. I., & Prosperi, E. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.02.011 · Cited by 56
Self-citationPerucca, P., Cazzalini, O., Mortusewicz, O., Necchi, D., Savio, M., Nardò, T., Stivala, L. A., Leonhardt, H., Cardoso, M. C., & Prosperi, E. (2006) · Journal of Cell Science · doi:10.1242/jcs.02868 · Cited by 55
Self-citationUV Induces p21 Rapid Turnover Independently of Ubiquitin and Skp2
Lee, H., Zeng, S. X., & Lu, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605366200 · Cited by 54
Zhan, J., Easton, J. B., Huang, S., Mishra, A., Xiao, L., Lacy, E. R., Kriwacki, R. W., & Houghton, P. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00086-06 · Cited by 53
Lin, P.-Y., Fosmire, S. P., Park, S., Park, J.-Y., Baksh, S., Modiano, J. F., & Weiss, R. H. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-16 · Cited by 53
Weiss, R. H., Marshall, D., Howard, L. L., Corbacho, A. M., Cheung, A., & Sawai, E. T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00495-0 · Cited by 52
Le, H.-V., Minn, A. J., & Massagué, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504689200 · Cited by 51
Hong, R., & Chakravarti, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303138200 · Cited by 47
The fellowship of the rings: distinct pools of proliferating cell nuclear antigen trimer at work
Prosperi, E. (2006) · The FASEB Journal · doi:10.1096/fj.05-5469hyp · Cited by 47
Self-citationBrouillard, F., & Crémisi, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307123200 · Cited by 42
Zhang, G., Park, M. A., Mitchell, C., Walker, T. D., Hamed, H. A., Studer, E. J., Graf, M. R., Rahmani, M., Gupta, S., Hylemon, P. B., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803444200 · Cited by 42
Savio, M., Stivala, L. A., Scovassi, A. I., Bianchi, L., & Prosperi, E. (1996) · PubMed · Cited by 42
Self-citationInhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein.
Mattock, H., Lane, D., & Warbrick, E. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5160 · Cited by 38
Wang, J., Devgan, V., Corrado, M., Prabhu, N. S., El‐Deiry, W. S., Riccardi, C., Pandolfi, P. P., Missero, C., & Dotto, G. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507976200 · Cited by 37
Poole, J. C., Thain, A., Perkins, N. D., & Roninson, I. B. (2004) · Cell Cycle · doi:10.4161/cc.3.7.971 · Cited by 35
p21WAF1 negatively regulates DNMT1 expression in mammalian cells
Tan, H. H., & Porter, A. G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.001 · Cited by 34
Esteve, V., Canela-Canela, N., Rodríguez-Vilarrupla, A., Aligué, R., Agell, N., Mingarro, I., Bachs, O., & Pérez‐Payá, E. (2003) · ChemBioChem · doi:10.1002/cbic.200300649 · Cited by 32
Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells
Stuart, S. A., & Wang, J. Y. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808810200 · Cited by 28
Redeuilh, G., Attia, A., Mešter, J., & Sabbah, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205753 · Cited by 28
Wani, M. A., Wani, G., Yao, J., Zhu, Q., & Wani, A. A. (2002) · Carcinogenesis · doi:10.1093/carcin/23.3.403 · Cited by 27
A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate
Pavelić, S. K., Čaćev, T., & Kralj, M. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.28 · Cited by 26
Direct Interaction of p21 with p50, the Small Subunit of Human DNA Polymerase Delta
Li, H., Xie, B., Rahmeh, A. A., Zhou, Y., & Lee, M. (2006) · Cell Cycle · doi:10.4161/cc.5.4.2425 · Cited by 21
Lee, J. Y., Kim, H. S., Kim, J. Y., & Sohn, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.160 · Cited by 20
Savio, M., Coppa, T., Cazzalini, O., Perucca, P., Necchi, D., Nardò, T., Stivala, L. A., & Prosperi, E. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.02.005 · Cited by 19
Self-citationTherrien, J., Loignon, M., Drouin, R., & Drobetsky, E. A. (2001) · PubMed · Cited by 17
The fate of p21CDKN1A in cells surviving UV-irradiation
Itoh, T., & Linn, S. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.08.008 · Cited by 17
(1995) · PubMed
Cited by
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“Moreover, telomere erosion triggers the DNA damage response (DDR; FIGURE 1), a signaling pathway in which ataxia-telangiectasia mutated (ATM) or ATM- and Rad3-related (ATR) kinases (83) block cell-cycle progression through stabilization of the p53 protein (130) and the transcriptional activation of the cyclin-dependen…”
Backgroundp53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
Ihry, R. J., Worringer, K. A., Salick, M. R., Frias, E., Ho, D., Theriault, K., Kommineni, S., Chen, J., Sondey, M., Ye, C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0050-6 · Cited by 978
Sp1 and the ‘hallmarks of cancer’
Beishline, K., & Azizkhan‐Clifford, J. (2015) · The FEBS Journal · doi:10.1111/febs.13148 · Cited by 524
Evaluation of the use of therapeutic peptides for cancer treatment
Marqus, S., Pirogova, E., & Piva, T. J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0328-x · Cited by 512
p21: a two-faced genome guardian.
Georgakilas, A. G., Martin, O. A., & Bonner, W. M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.001 · Cited by 489
Metadata
- Authors
- Cazzalini, O., Scovassi, A. I., Savio, M., Stivala, L. A., & Prosperi, E.
- Venue
- Mutation Research/Reviews in Mutation Research
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 704
- Issue
- 1-3
- Pages
- 12-20
- ISSN
- 1383-5742 (ISSN-L)
- OpenAlex
- W1990532502
- Cited by
- 433
- References
- 156
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.